Close Menu

JP Morgan Healthcare Conference

The firm expects full-year revenue growth of up to 39 percent, but fell short of prior guidance for the year.

Executives from Genomic Health, Meridian Bioscience, and Qiagen provided updates on their companies at the JP Morgan Healthcare Conference in San Francisco.

Developers said Illumina's decision to tap into the cancer screening market is not surprising because of its potentially huge size.

Westin St. Francis Hotel, San Francisco, site of the JP Morgan Healthcare Conference

Executives from Luminex, Exact Sciences, T2 Biosystems, and Singulex provided updates on their companies' businesses on the final day of the conference.

Executives from several life science research tool and diagnostic firms provided conference attendees with updates on their businesses.

The chemistry will be single-molecule, based on hybridization, and will not require amplification, enzymes, or library prep, the firm said.

Quiet Down

MedCity News says the real highlight of the JP Morgan Healthcare conference was when 23andMe CEO Anne Wojcicki was shushed for talking during her own company's presentation.

Executives from Thermo Fisher Scientific, Qiagen, Danaher, Counsyl, Human Longevity, and Adaptive Biotechnologies provided business updates to conference goers.

Executives from the sequencing tech firms provided attendees with an update on recently launched products and platforms, and future technology developments.

Executives from 23andMe, Myriad Genetics, Genomic Health, and Alere provided updates on their companies at the JP Morgan Healthcare Conference in San Francisco.

Pages

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.